NCT00633425View on ClinicalTrials.gov

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

October 31, 2003

Conditions
Diabetes Mellitus
Interventions
DRUG

GLIMEPIRIDE

Trial Locations (1)

Unknown

Sanofi-Aventis, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00633425 - Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride | Biotech Hunter | Biotech Hunter